SB431542: Difference between revisions
Jump to navigation
Jump to search
imported>Kevin No edit summary |
imported>Xenbase |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 22: | Line 22: | ||
==References== | ==References== | ||
*[http://www.xenbase.org/literature/article.do?method=display&articleId=371 Ho et al., 2006] | *[http://www.xenbase.org/literature/article.do?method=display&articleId=371 Ho et al., 2006] | ||
*[https://pubchem.ncbi.nlm.nih.gov/ | *[http://www.xenbase.org/literature/article.do?method=display&articleId=49634 Chiu 2014] | ||
*[http://www.xenbase.org/literature/article.do?method=display&articleId=54570 Sato et al 2018] | |||
*[https://pubchem.ncbi.nlm.nih.gov/compound/4521392 NCBI PubChem CID:4521392] | |||
> | > 40 Xenbase articles contain a reference to SB431542 according to [http://www.xenbase.org/cgi-bin/textpresso/xenopus/search textpresso] | ||
* | * | ||
*[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | *[[Small Molecules for Xenopus Research|Back To Small Molecules Home Page]] | ||
Latest revision as of 12:19, 9 April 2018
Description
"Potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor activin receptor-like kinase ALK5 (IC50 = 94 nM), and its relatives ALK4 and ALK7. Suppresses TGF-β-induced proliferation of human osteosarcoma cells. Stimulates proliferation, differentiation and sheet formation of ESC-derived endothelial cells."
- -Tocris Product Description
Genes Affected
Suppliers
Usage Notes
References
> 40 Xenbase articles contain a reference to SB431542 according to textpresso